MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $574,676 | +24.0% | 445,485 | +26.9% | 0.02% | +17.6% |
| Q2 2023 | $463,300 | +7.9% | 350,985 | -42.2% | 0.02% | 0.0% |
| Q1 2023 | $429,442 | +84.4% | 607,500 | +95.7% | 0.02% | +54.5% |
| Q4 2022 | $232,875 | -12.8% | 310,500 | 0.0% | 0.01% | -15.4% |
| Q3 2022 | $267,000 | +13.6% | 310,500 | +47.9% | 0.01% | +18.2% |
| Q2 2022 | $235,000 | -3.3% | 210,000 | -3.2% | 0.01% | 0.0% |
| Q1 2022 | $243,000 | +125.0% | 217,051 | +221.6% | 0.01% | +83.3% |
| Q4 2021 | $108,000 | -81.5% | 67,501 | -72.0% | 0.01% | -79.3% |
| Q3 2021 | $584,000 | -70.6% | 241,413 | -61.5% | 0.03% | -62.3% |
| Q2 2021 | $1,986,000 | +836.8% | 626,421 | +898.0% | 0.08% | +1000.0% |
| Q1 2021 | $212,000 | -87.1% | 62,767 | -86.4% | 0.01% | -91.7% |
| Q4 2020 | $1,647,000 | +41.7% | 460,051 | +3.7% | 0.08% | +6.3% |
| Q3 2020 | $1,162,000 | – | 443,517 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |